Harvard Homepage
The COVID-19 vaccine is just the most recent in Harvard’s long history of researching, treating, and helping to eradicate illnesses and diseases.
A watershed moment for vaccines
Vaccines are underfunded, understudied, and underappreciated as a vital tool in public health. Could COVID-19 be the start of a vaccine renaissance?
Read moreCOVID-19 vaccine safety
Over the past year, results from a series of clinical trials have demonstrated the efficacy and safety of COVID-19 vaccines in preventing serious illness, hospitalizations, and deaths.
COVID-19 vaccine safetyNew research at Harvard Medical School
Scientists explore a new single-shot COVID vaccine
Peak immunity appears to last at least 11 months.
On the front line
Harvard faculty have been researching COVID-19 and working to develop effective COVID-19 vaccines and therapies.
Dan H. Barouch
Dan Barouch was awarded Harvard’s George Ledlie Prize for his work on the Johnson & Johnson COVID-19 vaccine.
Kizzmekia S. Corbett
Leading coronavirus scientist, Kizzmekia S. Corbett, joined the Harvard T.H. Chan School of Public Health to continue vaccine development research.
Jagpreet Chhatwal
Using a simulator that models the trajectory of COVID-19 in the U.S., Jagpreet Chhatwal predicts that the delta variant, along with other factors, will likely lead to a surge in COVID-19–related deaths.
How vaccines work
The mRNA COVID vaccine uses established research to create a safe and effective defense against coronavirus. In this video we explain how it works.
LabXchange Simulation
Could you make a COVID-19 vaccine?
In this simulation you can design a sequence of experiments to generate a coronavirus vaccine.
History: past pandemics
Benjamin Waterhouse, co-founder of Harvard Medical School, is known as the first doctor to test the smallpox vaccine in the United States. The Countway Library features artifacts of his time in a virtual exhibit.
The future of vaccines
Scientists and researchers at Harvard are hard at work developing new and better vaccines.
Cancer vaccines
Read the transcript
In this Wyss podcast, researchers discuss their collaboration developing an injectable cancer vaccine.
Learn about a different, implantable cancer vaccine also developed at the Wyss Institute.
Biomaterial vaccines
Effective vaccines could act as a defense against bacterial infections and some of their most severe consequences, including sepsis.
Melanoma vaccines
Personalized vaccines designed to fight melanoma, the deadliest form of skin cancer, maintain their effects on the immune system years after inoculation.
Keep learning
Join the Harvard community and learn more about vaccines and health, along with many other topics.
YOU MAY ALSO LIKE